33PCombination of mTOR inhibition and paclitaxel as a personalised strategy in the context of MYC-amplified high-grade serous ovarian cancerF C Martins, D-L Couturier,I de Santiago,M Vias, D Sanders,A Piskorz, J Hall, M Jimenez-Linan, K Hosking,R Crawford,J BrentonAnnals of Oncology（2019）引用 2|浏览14暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
